LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
BT-20 CP724714
0.12
uM
LJP5
 0.9474 0.0139 0.9236 0.0201
BT-20 CP466722
0.12
uM
LJP5
 1.0458 0.0179 1.0663 0.0254
BT-20 Crizotinib
0.12
uM
LJP5
 0.9395 0.0132 0.9128 0.0182
BT-20 Momelotinib
0.12
uM
LJP5
 0.9071 0.0207 0.8659 0.0287
BT-20 Dasatinib
0.12
uM
LJP5
 0.6189 0.0085 0.4476 0.0197
BT-20 Dasatinib
0.12
uM
LJP6
 0.4412 0.0831 0.1947 0.1078
BT-20 Dovitinib
0.12
uM
LJP5
 0.7575 0.0565 0.6518 0.0760
BT-20 Enzastaurin
0.12
uM
LJP5
 1.0467 0.0287 1.0661 0.0412
BT-20 Erlotinib
0.12
uM
LJP5
 0.9124 0.0254 0.8745 0.0346
BT-20 Foretinib
0.12
uM
LJP5
 0.8541 0.0646 0.7849 0.0984
BT-20 R406
0.12
uM
LJP6
 0.9593 0.0262 0.9399 0.0391
BT-20 Pictilisib
0.12
uM
LJP6
 0.7414 0.0309 0.6259 0.0419
BT-20 Gefitinib
0.12
uM
LJP6
 0.9531 0.0547 0.9347 0.0779
BT-20 Geldanamycin
0.12
uM
LJP5
 0.3227 0.0223 0.0173 0.0505
BT-20 Geldanamycin
0.12
uM
LJP6
 0.3088 0.0187 -0.0016 0.0319
BT-20 GSK1059615
0.12
uM
LJP5
 0.7832 0.0163 0.6867 0.0177
BT-20 GSK1059615
0.12
uM
LJP6
 0.6487 0.0872 0.4950 0.1202
BT-20 GSK1904529A
0.12
uM
LJP6
 0.9012 0.0224 0.8582 0.0301
BT-20 Omipalisib
0.12
uM
LJP6
 0.2393 0.0230 -0.1015 0.0237
BT-20 GSK 690693
0.12
uM
LJP5
 0.8316 0.0341 0.7578 0.0450
BT-20 GW843682X
0.12
uM
LJP6
 0.6865 0.0839 0.5506 0.1145
BT-20 HG-5-113-01
0.12
uM
LJP5
 0.9182 0.0046 0.8815 0.0068
BT-20 HG-5-88-01
0.12
uM
LJP6
 0.9192 0.0243 0.8817 0.0378
BT-20 Imatinib
0.12
uM
LJP6
 0.9957 0.0312 0.9923 0.0460
BT-20 JNK-9L
0.12
uM
LJP6
 0.8176 0.0481 0.7382 0.0662